SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-092766
Filing Date
2020-08-10
Accepted
2020-08-10 16:29:25
Documents
14
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2027116d1_8k.htm   iXBRL 8-K 25699
2 EXHIBIT 99.1 tm2027116d1_ex99-1.htm EX-99.1 93450
6 GRAPHIC image_001.jpg GRAPHIC 211029
  Complete submission text file 0001104659-20-092766.txt   594672

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20200810.xsd EX-101.SCH 3189
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20200810_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20200810_pre.xml EX-101.PRE 22712
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2027116d1_8k_htm.xml XML 3615
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 201089792
SIC: 2834 Pharmaceutical Preparations